Latest Insider Transactions at Treace Medical Concepts, Inc. (TMCI)
This section provides a real-time view of insider transactions for Treace Medical Concepts, Inc. (TMCI). The data is sourced from Form 4 filings with the SEC, which are filed by insiders of TREACE MEDICAL CONCEPTS, INC. to disclose their transactions in the company's securities. By reviewing this information, investors can gain insights into the trading activity of TREACE MEDICAL CONCEPTS, INC.'s insiders and make more informed investment decisions.
Insider Transaction List
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Apr 27
2021
|
John K Bakewell |
BUY
Conversion of derivative security
|
Indirect |
342,300
+50.0%
|
-
|
|
Apr 27
2021
|
John R Treace Director |
SELL
Open market or private sale
|
Indirect |
401,250
-14.82%
|
$6,821,250
$17.0 P/Share
|
|
Apr 27
2021
|
John R Treace Director |
BUY
Conversion of derivative security
|
Indirect |
427,875
+13.65%
|
-
|
|
Apr 27
2021
|
Mark Hair Chief Financial Officer |
BUY
Open market or private purchase
|
Indirect |
3,600
+50.0%
|
$61,200
$17.0 P/Share
|
|
Apr 27
2021
|
Mark Hair Chief Financial Officer |
BUY
Open market or private purchase
|
Direct |
10,000
+50.0%
|
$170,000
$17.0 P/Share
|
|
Apr 27
2021
|
Richard W Mott |
BUY
Conversion of derivative security
|
Direct |
699,141
+29.17%
|
-
|
|
Apr 27
2021
|
Thomas E Timbie Director |
BUY
Conversion of derivative security
|
Indirect |
299,509
+9.6%
|
-
|
|
Apr 27
2021
|
John T. Treace Chief Executive Officer |
SELL
Open market or private sale
|
Direct |
5,253,805
-47.03%
|
$89,314,685
$17.0 P/Share
|
|
Apr 27
2021
|
John T. Treace Chief Executive Officer |
BUY
Conversion of derivative security
|
Direct |
299,510
+2.61%
|
-
|
|
Apr 27
2021
|
Joe W. Ferguson SVP, Research & Development |
BUY
Conversion of derivative security
|
Indirect |
85,575
+50.0%
|
-
|